Fairscale Capital, LLC Merck & Co., Inc. Transaction History
Fairscale Capital, LLC
- $145 Billion
- Q3 2025
A detailed history of Fairscale Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fairscale Capital, LLC holds 3,994 shares of MRK stock, worth $370,882. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,994
Previous 3,994
-0.0%
Holding current value
$370,882
Previous $312 Million
8.47%
% of portfolio
0.23%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...